These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 11680574

  • 21. Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in mice.
    Mottram PL, Pietersz GA, Smyth MJ, Purcell LJ, Clunie GJ, McKenzie IF.
    Transplantation; 1993 Mar; 55(3):484-90. PubMed ID: 8456465
    [Abstract] [Full Text] [Related]

  • 22. Immunosuppressive effect of monoclonal antibodies to ICAM-1 and LFA-1 on peripheral nerve allograft in mice.
    Nakao Y, Mackinnon SE, Strasberg SR, Hertl MC, Isobe M, Susskind BM, Mohanakumar T, Hunter DA.
    Microsurgery; 1995 Mar; 16(9):612-20. PubMed ID: 8747285
    [Abstract] [Full Text] [Related]

  • 23. [Selective immunosuppression with monoclonal antibodies against ICAM-1 and LFA-1 with FK 506 after experimental small intestine transplantation in the rat].
    Gasser M, Otto C, Timmermann W, Gassel HJ, Ulrichs K, Thiede A.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Mar; 115(Suppl I):595-9. PubMed ID: 14518324
    [Abstract] [Full Text] [Related]

  • 24. Intercellular adhesion molecule-1/LFA-1 cross talk is a proximate mediator capable of disrupting immune integration and tolerance mechanism at the feto-maternal interface in murine pregnancies.
    Blois S, Tometten M, Kandil J, Hagen E, Klapp BF, Margni RA, Arck PC.
    J Immunol; 2005 Feb 15; 174(4):1820-9. PubMed ID: 15699108
    [Abstract] [Full Text] [Related]

  • 25. Prevention of fetal bowel allograft rejection by combined treatment with anti-ICAM-1 and anti-LFA-1 antibodies.
    Kato Y, Yamataka A, Yagita H, Bashuda H, Okumura K, Miyano T.
    J Pediatr Surg; 1995 Jul 15; 30(7):1093-7. PubMed ID: 7472940
    [Abstract] [Full Text] [Related]

  • 26. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities.
    Stepkowski SM, Tu Y, Condon TP, Bennett CF.
    J Immunol; 1994 Dec 01; 153(11):5336-46. PubMed ID: 7963586
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S, Omoto K, Kanemitsu I, Setoguchi K, Ishida H, Tanabe K, Suzuki T, Tashiro Y, Kishimoto H, Abe R.
    Exp Clin Transplant; 2012 Aug 01; 10(4):375-85. PubMed ID: 22758208
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Combination of anti-ICAM-1 and anti-LFA-1 monoclonal antibody therapy prolongs allograft survival in rat hind-limb transplants.
    Ozer K, Siemionow M.
    J Reconstr Microsurg; 2001 Oct 01; 17(7):511-7; discussion 518. PubMed ID: 11598825
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Transplantation tolerance by a combined therapy with sulfatide, anti-LFA-1/ICAM-1 monoclonal antibodies and FK506 in rat cardiac transplantation.
    Horimoto H, Ito T, Hayashi T, Miyasaka M, Nozawa M.
    Transpl Int; 1998 Oct 01; 11 Suppl 1():S310-2. PubMed ID: 9665003
    [Abstract] [Full Text] [Related]

  • 35. Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506.
    Bashuda H, Takazawa K, Tamatani T, Miyasaka M, Yagita H, Okumura K.
    Transplantation; 1996 Jul 15; 62(1):117-22. PubMed ID: 8693525
    [Abstract] [Full Text] [Related]

  • 36. Blocking of ICAM-1 and LFA-1 in rat liver transplantation.
    Degawa H, Watanabe K, Uchida H, Nagao T, Tomikawa S, Beck Y, Nomura Y, Ichikawa N, Ando Y, Kikuchi K, Ito S.
    Transplant Proc; 1996 Jun 15; 28(3):1362-3. PubMed ID: 8658695
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Preventing effect of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies on murine islet allograft rejection.
    Arai K, Sunamura M, Wada Y, Takahashi M, Kobari M, Kato K, Yagita H, Okumura K, Matsuno S.
    Int J Pancreatol; 1999 Aug 15; 26(1):23-31. PubMed ID: 10566155
    [Abstract] [Full Text] [Related]

  • 39. Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in mice.
    Mottram PL, Han WR, Murray-Segal LJ, Mandel TE, Pietersz GA, McKenzie IF.
    Transplantation; 1997 Sep 15; 64(5):684-90. PubMed ID: 9311703
    [Abstract] [Full Text] [Related]

  • 40. Immunosuppression by aminopterin or idarubicin conjugated to anti-CD8 in the mouse heart allograft model.
    Mottram PL, Pietersz GA, Purcell LJ, Krauer K, McKenzie IF.
    Transplant Proc; 1992 Oct 15; 24(5):2301. PubMed ID: 1413068
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.